Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...
SAN FRANCISCO (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its ...
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...
But now that these drugs are in greater demand from both patients and doctors, state Medicaid programs are grappling with whether to cover them for weight loss, both for reasons of equity and to save ...
CarboFire: A Clear Solution By focusing on AMPK activation, CarboFire addresses the enzyme deficiency that silently sabotages ...
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...
President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...
Trump has pledged to implement "very high" tariffs on Denmark if it does not sell Greenland to the United States, also noting ...
Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...
President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...